SoftBank
Group CEO Masayoshi Son has ruined his name in the investment
community. His botched investments in WeWork, Uber, and Slack, just to
name a few, could result in billions of dollars in losses for SoftBank
Group Corp., according to Bloomberg, who compiled several notes from
Wall Street analysts detailing the turmoil.
Profit estimates for SoftBank's Vision Fund were slashed by $5.4
billion to an operating loss of $3.5 billion for 3Q19, wrote Mitsubishi
UFJ Morgan Stanley Securities Co, in a recent note. Most of the losses
were due to drastic valuation declines of Uber and Slack, and a massive
writedown of WeWork after the shelved IPO collapsed valuations last
month.
Sanford C. Bernstein & Co. believes SoftBank's Vision Fund could
write down as much as $5.93 billion of WeWork, and SoftBank Group could
writedown another $1.24 billion.
Tanaka said Uber's 35% drop in 15 weeks was a massive reason for
Vision Fund's awful 2Q19 performance. He also reduced SoftBank Group's
fiscal year operating profit to $9.446 billion, from $14.861 billion.
Chris Lane, an analyst at Sanford C. Bernstein, said SoftBank might
record a $3.54 billion drop in the value of its Uber stake and $350 loss
in Slack. Lane believes the combined writedown for WeWork could be
$2.82 billion, but that is based on WeWork's valuation sliding to $15
billion from $24 billion. And as we've reported, WeWork could be worth
$10 billion to $12 billion, a dramatic discount from the $47 billion
valuation seen earlier this year.
It was only yesterday when Son spoke with Nikkei Business magazine, and said he is "embarrassed and flustered" by his recent track record.
孫正義が日経ビジネスに昨日語ったところでは、「当惑、失望している」ということだ。
"The results still have a long way to go and that makes me
embarrassed and impatient," said Son. "I used to envy the scale of the
markets in the U.S. and China, but now you see red-hot growth companies
coming out of small markets like in Southeast Asia. There is just no
excuse for entrepreneurs in Japan, myself included."
If macroeconomic headwinds continue to mount in the global economy,
technology unicorn valuations will reset further, meaning that
SoftBank's Vision Fund will continue to incur steep losses and massive
writedowns through 2020.
As we've highlighted in the last several weeks, the global IPO and M&A markets are starting to falter -- this will further stress Vision Fund as their ability to cash out of technology unicorns are coming to an end for the year.
We even reported last week that veteran venture capitalists called an emergency meeting of the technology unicorns in Silicon Valley to advise them on the turbulent times ahead.
米国はよく理解してませんが、日本の場合では量的緩和で日銀が国債買い上げした資金は日銀当座預金にそのままです、市中には流れていません。でもNHKのニュース等では「ジャブジャブ」という表現をアナウンサーが使い、さらに丁寧に水道の蛇口からお金が吐き出される画像まで示してくれます。これって心理効果が大きいですよね。量的緩和とは何かを7時のニュースや新聞でこれ以上丁寧に解説するのはそう簡単ではありません。一般の人も株式をやっている人も「イメージ」で捉える以上はそう簡単にできません。多くの人は量的緩和とはなにか、を理解していないと私は想像しています。 ただし、国債を買い上げるので長期金利が低下し住宅ローン金利等が下がったのは確実な効果です。一方で長短金利差が少なくなると銀行のビジネスモデルが成り立たなくなりますが。 This Is The One Chart Every Trader Should Have "Taped To Their Screen" by Tyler Durden Sat, 01/19/2019 - 18:55 After a year of tapering, the Fed’s balance sheet finally captured the market’s attention during the last three months of 2018. 一年間のテーパリング後、FEDバランスシートがとうとう市場の注目をあびることになった、2018年の最後の3ヶ月だ。 By the start of the fourth quarter, the Fed had finished raising the caps on monthly roll-off of its balance sheet to the full $50bn per month (peaking at $30bn USTs, $20bn MBS...
多量のオピオイドを米国に送り込み、米国で深刻な麻薬中毒問題を引き起こしています。現代版「阿片戦争」です。あのトヨタ初の女性取締役もオピオイド中毒で逮捕解任されましたよね。 US Is Dependent On China For Almost 80% Of Its Medicine by Tyler Durden Fri, 05/31/2019 - 12:55 Experts are warning that the U.S. has become way too reliant on China for all our medicine , our pain killers, antibiotics, vitamins, aspirin and many cancer treatment medicine. 専門家はこう警告する、米国はすべての医薬品、痛み止め、抗生物質、ビタミン、アスピリン、各種抗がん剤で、中国依存度が高すぎる。 Fox Business reports that according to FDA estimates at least 80 percent of active ingredients found in all of America’s medicine come from abroad, primarily from China . And it’s not just the ingredients, China wants to become the world’s dominant generic drug maker. So far Chinese companies are making generic for everything from high blood pressure to chemotherapy drugs. 90 percent of America’s prescriptions a...
Amazonで買物をしてContrarianJを応援しよう Supply and Demand in Comex Digital Gold by Sprott Money Thu, 07/04/2019 - 09:32 Supply and Demand in Comex Digital Gold Written by Craig Hemke, Sprott Money News A few years ago, we wrote the salient article on the subject of derivative supply and demand on Comex. Given the recent price breakout and sentiment change, it's likely a good idea to re-visit this topic today. 数年前のことだが、私どもはCOMXの派生商品の需給に関する注目記事を書いた。最近の価格ブレークアウトと心理変化もあり、この話題を再度今取り上げるのが良かろう。 The post from 2017 dealt with Comex silver and the original link is below. However, since it is extremely important that you understand this dynamic, I'm going to ask the folks at Sprott Money to reprint the post in its entirely at the bottom of this page. Please take the time to read and study this full article: 2017年の記事はCOMEXシルバーに関するもので、その時のリ...